VIR - CIK 0001706431
Vir Biotechnology, Inc. (VIR) reported revenue of $68.56M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $68.56M | -7.6% |
| FY 2024 | $74.20M | -13.9% |
| FY 2023 | $86.18M | -94.7% |
| FY 2022 | $1.62B | +47.5% |
| FY 2021 | $1.10B | +1334.4% |
| FY 2020 | $76.37M | +843.9% |
| FY 2019 | $8.09M | -24.2% |
| FY 2018 | $10.67M | +293.9% |
| FY 2017 |
Vir Biotechnology, Inc. (VIR) reported revenue of $68.56M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2017 and fiscal 2025, Vir Biotechnology, Inc.'s revenue grew from $2.71M to $68.56M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.71M |
| - |